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Abstract
Background
Data are lacking from physical activity (PA) trials with long-term follow-up of both objectively
measured PA levels and robust health outcomes. Two primary care 12-week pedometer-
based walking interventions in adults and older adults (PACE-UP and PACE-Lift) found
sustained objectively measured PA increases at 3 and 4 years, respectively. We aimed to
evaluate trial intervention effects on long-term health outcomes relevant to walking interven-
tions, using routine primary care data.
Methods and findings
Randomisation was from October 2012 to November 2013 for PACE-UP participants from
seven general (family) practices and October 2011 to October 2012 for PACE-Lift partici-
pants from three practices. We downloaded primary care data, masked to intervention or
control status, for 1,001 PACE-UP participants aged 45–75 years, 36% (361) male, and 296
PACE-Lift participants, aged 60–75 years, 46% (138) male, who gave written informed con-
sent, for 4-year periods following randomisation. The following new events were counted for
all participants, including those with preexisting diseases (apart from diabetes, for which
existing cases were excluded): nonfatal cardiovascular, total cardiovascular (including
fatal), incident diabetes, depression, fractures, and falls. Intervention effects on time to first
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event post-randomisation were modelled using Cox regression for all outcomes, except for
falls, which used negative binomial regression to allow for multiple events, adjusting for age,
sex, and study. Absolute risk reductions (ARRs) and numbers needed to treat (NNTs) were
estimated. Data were downloaded for 1,297 (98%) of 1,321 trial participants. Event rates
were low (<20 per group) for outcomes, apart from fractures and falls. Cox hazard ratios for
time to first event post-randomisation for interventions versus controls were nonfatal cardio-
vascular 0.24 (95% confidence interval [CI] 0.07–0.77, p = 0.02), total cardiovascular 0.34
(95% CI 0.12–0.91, p = 0.03), diabetes 0.75 (95% CI 0.42–1.36, p = 0.34), depression 0.98
(95% CI 0.46–2.07, p = 0.96), and fractures 0.56 (95% CI 0.35–0.90, p = 0.02). Negative
binomial incident rate ratio for falls was 1.07 (95% CI 0.78–1.46, p = 0.67). ARR and NNT
for cardiovascular events were nonfatal 1.7% (95% CI 0.5%–2.1%), NNT = 59 (95% CI 48–
194); total 1.6% (95% CI 0.2%–2.2%), NNT = 61 (95% CI 46–472); and for fractures 3.6%
(95% CI 0.8%–5.4%), NNT = 28 (95% CI 19–125). Main limitations were that event rates
were low and only events recorded in primary care records were counted; however, any
underrecording would not have differed by intervention status and so should not have led to
bias.
Conclusions
Routine primary care data used to assess long-term trial outcomes demonstrated signifi-
cantly fewer new cardiovascular events and fractures in intervention participants at 4 years.
No statistically significant differences between intervention and control groups were demon-
strated for other events. Short-term primary care pedometer-based walking interventions
can produce long-term health benefits and should be more widely used to help address the
public health inactivity challenge.
Trial registrations
PACE-UP isrctn.com ISRCTN98538934; PACE-Lift isrctn.com ISRCTN42122561.
Author summary
Why was this study done?
• Health benefits from physical activity interventions require sustained increases in physi-
cal activity levels, yet evidence of long-term objective increases in physical activity and
effects on health outcomes is lacking.
• Routine data from primary care records can provide robust health outcome measures
but have been little used in evaluating physical activity interventions.
What did the researchers do and find?
• Two primary care 12-week pedometer-based walking interventions in 45- to 75-year-
olds increased objectively measured moderate-to-vigorous physical activity levels by
Long-term health outcomes following 2 pedometer interventions
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002836 June 25, 2019 2 / 20
in a repository. The link is https://doi.org/10.24376/
rd.sgul.8138174.
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one-third between baseline and 3–4 years and were associated with significant decreases
in both cardiovascular events (heart attacks, strokes, etc.) and fractures at 4 years.
• Approximately 60 people needed to receive the walking intervention to prevent one car-
diovascular event and approximately 28 people to prevent one fracture.
What do these findings mean?
• Short-term pedometer-based walking interventions can help adults and older adults to
achieve not only sustained increases in physical activity but also important long-term
health benefits.
• Routine primary care data provide an efficient way to provide long-term trial follow-up
for assessing health outcomes.
Introduction
Strong evidence exists that physical activity (PA) is protective for a wide range of health condi-
tions [1–3], and inactivity is claimed to be the fourth leading risk factor for global mortality
[2]. Meta-analyses of cohort studies have reported clear benefits of moderate-intensity PA for
many chronic diseases, including diabetes [4], ischaemic heart disease [4], stroke [4], fractures
[5], and depression [6]. However, all these estimates are based on evidence from observational
cohort studies, in which individual baseline differences in PA levels, assessed by question-
naires, were linked to subsequent disease outcomes. PA questionnaires are known to be inac-
curate and subject to recall bias [7], and there is the possibility of regression dilution bias in
such studies, which would lead to underestimating benefits. This raises the question of whether
changes in PA that occur after PA interventions will have similar or possibly larger effects.
An additional advantage of trial data is that changes in PA have usually been objectively
measured.
Many PA interventions, including pedometer-based walking interventions, have shown
short-term increases in PA levels [8–10], but to achieve the long-term health benefits demon-
strated above in cohort studies, increases in PA need to be sustained, and long-term trial data
with objectively measured PA outcomes and robust health outcomes are limited, with calls for
more such trials [10–12]. The Finnish Diabetes Prevention Study observed significant PA
increases and showed impressive 58% reductions in type 2 diabetes, but it combined dietary
and PA interventions; therefore, it is difficult to estimate independent PA effects [13]. In con-
trast, a recent large primary care trial failed to reduce type 2 diabetes incidence, despite
increasing PA levels [14]. Trials examining PA effects on cardiovascular outcomes have shown
mixed results: some showing strong protective effects on both heart attacks [15,16] and strokes
[16] but others failing to reduce cardiovascular events [17]. Primary care trials that have suc-
cessfully increased PA levels have shown both increased [18] and reduced [19] self-reported
falls, but a systematic review of exercise interventions in older adults demonstrated a signifi-
cant reduction in fall-related fractures [20]. A meta-analysis of PA interventions demonstrated
a reduction in depressive symptoms [21]. However, only one of the trials above used routinely
recorded primary care or hospital data to capture events [15]; for other trials, participants were
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asked about health events, and these were validated by checking patient records, leading to
important potential reporting bias. The benefit of using routine electronic records for
extended follow-up of trials has been established in a different context by the West of Scotland
Coronary Prevention Study, which showed that routine records gave very similar results to rig-
orously collected clinical trial data for cardiovascular events and deaths [22]. Using routine
records in trials has the additional merit that if participants have given permission to access
their health records, these may be available even when participants are lost to follow-up.
We conducted two pedometer-based walking trials with adults and older adults (PACE-UP,
PACE-Lift), which increased accelerometer-measured step count and moderate-to-vigorous
PA (MVPA) levels in bouts at 12 months [23,24] and with sustained PA increases at 3–4 years
[25]. Across both trials at 3–4 years, all intervention groups were doing approximately an extra
30 minutes per week of MVPA compared with baseline, up about a third on their baseline lev-
els [25]. Both trials recruited through primary care, and participant consent to link trial data
with primary care record data was sought. The aim of the present paper was to evaluate the
intervention effects from PACE-UP and PACE-Lift on longer-term health outcomes relevant
to the walking interventions, using routinely collected primary care data.
Methods
Study design and participants
Two primary care randomised controlled trials (RCTs) of effective 12-week pedometer-based
walking interventions are included, both providing long-term health outcome data from rou-
tine primary care records: PACE-UP, which recruited 45- to 75-year-olds from seven London
(United Kingdom) practices from October 2012 to November 2013, and PACE-Lift, which
recruited 60- to 75-year-olds from three Berkshire and Oxfordshire (UK) practices from Octo-
ber 2011 to October 2012. The trials were similar in their primary care recruitment and in the
12-week pedometer-based walking interventions, incorporating behaviour-change techniques
[26, 27]. Participants were very similar in terms of their baseline characteristics, apart from
deprivation level (see Table 1), but randomisation ensured even distribution of deprivation
levels across intervention and control groups [23,24], and deprivation was not an effect modi-
fier [23]. At long-term follow-up, 3-year findings for both PACE-UP intervention groups
(postal and nurse-supported) and 4-year findings from the PACE-Lift (nurse-supported)
intervention group all showed very similar effects on PA levels [25]. Given the similarities of
these trials and their sustained PA effects, we therefore present a combined analysis of all three
intervention groups at 4 years on primary care outcomes. All analyses adjust for study as a
covariate.
PACE-UP trial. Trial methods are published [27], as are 3- and 12-month [23] and 3-year
[25] findings, cost-effectiveness analyses [28], and funder’s report [29]. All research partici-
pants gave written informed consent, and permission was sought for researchers to access
data from their primary care records. Ethical approval was granted by London Hampstead
Research Ethics Committee (REC) (UK) (12L/LO/0219), including substantial amendments
for extended follow-up work. The trial had a control arm (usual care) and two intervention
arms: postal, who received the 12-week PACE-UP walking programme (pedometer, hand-
book, and PA diary) by post, and nurse-supported, who received the same materials at the first
of three practice nurse PA consultations. Baseline findings for participants included in primary
care outcomes analyses are summarised in Table 1, and the postal and nurse interventions are
summarised in Table 2. The handbook and diary are available at www.paceup.sgul.ac.uk/
materials. The protocol, approved by ethics before extended follow-up commenced, included
details of long-term follow-up, primary care data download procedures, and primary care data
Long-term health outcomes following 2 pedometer interventions
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Table 1. Baseline characteristics of the PACE-UP and PACE-Lift cohorts.
PACE-UP study (N = 1,001) PACE-Lift study (N = 297)a
n (%) n (%)
Age at randomisation
45–59 years 520 (52%) 0 (0%)
60–75 years 481 (48%) 297 (100%)
Gender: male 361 (36%) 138 (46%)
Marital status: married 645 (66%) 240 (81%)
National quintiles of Index of Multiple Deprivation rank
1–3 (most deprived) 553 (57%) 29 (10%)
4 212 (22%) 51 (17%)
5 (least deprived) 201 (21%) 217 (73%)
Ethnicity
White 776 (80%) 289 (99%)
Asian/Asian British 68 (7%) 2 (1%)
Black/African/Caribbean/Black British 96 (10%) 1 (0%)
Other 24 (2%) 1 (0%)
Current smoker 80 (8%) 16 (6%)
General healthb: Very good or good 802 (82%) 259 (89%)
Self-reported painb 674 (69%) 201 (69%)
Limiting long-standing illness 216 (22%) 72 (26%)
Townsend disability scoreb
None (0) 586 (59%) 205 (70%)
Slight or some disability (1–6) 371 (38%) 83 (28%)
Appreciable or severe disability (7–18) 29 (3%) 6 (2%)
HADS depression scoreb: borderline or high 108 (11%)
Geriatric depression scoreb: high 19 (7%)
Overweight/obese: BMI� 25kg/m2 666 (67%) 200 (67%)
Preexisting disease on GP records
Cardiovascular disease 64 (6%) 31 (10%)
Diabetes 70 (7%) 18 (6%)
Depression 99 (10%) 34 (11%)
Accelerometry data
Average adjusted baseline step count per day
Mean (sd) 7,492 (2,675) 7,331 (2,829)
Median (IQR) 7,344 (5,567–9,106) 7,043 (5,302–9,124)
Total weekly minutes of MVPA in�10-minute
bouts
Mean (sd) 94 (102) 92 (109)
Median (IQR) 65 (21 to 133) 53 (3 to 140)
aOne PACE-Lift participant in the control group died before 12 months and is included in this table. The participant
is not included in the analysis of primary care record data but is included in the fatal + nonfatal cardiovascular events
analysis.
bFull references for general health, self-reported pain, Townsend disability score, HADS score, and geriatric
depression score are given in the trial protocols [26,27].
Abbreviations: BMI, body mass index; GP, general practitioner; HADS, hospital anxiety and depression scale; IQR,
interquartile range; MVPA, moderate to severe physical activity.
https://doi.org/10.1371/journal.pmed.1002836.t001
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outcomes and is included (S1 Text), as is a CONSORT checklist for primary care data follow-
up (S2 Text).
PACE-Lift trial. Trial methods are published [26], as are 3- and 12-month [24] and
4-year [25] findings. Written informed consent was gained from all participants, and permis-
sion was sought for researchers to access data from participants’ primary care records. Initial
ethical approval was granted by Oxfordshire REC C (UK) (11/H0606/2) up to 12-month fol-
low-up; the study was then closed and new ethical approval from this REC was granted for
Table 2. Components of interventions for PACE-UP and PACE-Lift trialsa.
Component PACE-UP PACE-Lift
Postal Nurse Nurse
Pedometer Yamax Digi-Walker
(Tokyo, Japan) SW-200. Provides
step count, requires daily manual
recording and resetting
Posted with instructions for useb Given with instructions by nurse at first
appointment
Given with instructions by nurse at first
appointment
Dedicated practice nurse PA
consultations (including
behaviour-change techniques)
Not applicable 3 consultations 4 consultations,
Week 1 “First Steps” (approx. 30 mins) Week 1 “First Steps” (approx. 45 mins)
Week 5 “Continuing the Changes”
(approx. 20 mins)
Week 3 “Continuing the Changes”
(approx. 30 mins)
Week 9 “Building Lasting Habits”
(approx. 20 mins)
Week 7 “Keeping up the Changes”
(approx. 30 mins)
Week 11 “Building Lasting Habits”
(approx. 30 mins)
Accelerometer feedback as part of
intervention
Not applicable Not applicable Actigraph GT3X+ (accelerometer) worn
for 1 week prior to each nurse
appointment. Nurse downloaded
accelerometer data during consultation
and provided immediate feedback on time
spent in sedentary, light, moderate, and
vigorous PA levels in relation to activities
recorded in PA diary.
Handbook (including behaviour-
change techniques)
Postedb Given by nurse at first appointment Given by nurse at first appointment
Target-setting: step count goals
and PA goals and use of walking
planner
Blinded pedometer (Yamax DigiWalker
CW200) worn for 7 days at baseline to
calculate average daily baseline steps,
used to set step count targets. Use of
12-week walking planner. Advised to
add 1,500 steps/day and then 3,000
steps/day to average baseline steps in
graded manner over 12 weeks.
Blinded pedometer (Yamax DigiWalker
CW200) worn for 7 days at baseline to
calculate average daily baseline steps,
used to set step count targets. Use of
12-week walking planner. Advised to add
1,500 steps/day and then 3,000 steps/day
to average baseline steps in a graded
manner over 12 weeks.
Nurses discussed appropriate step count
and PA goals with participants based on
baseline step count and weekly time in
MVPA from accelerometry and any health
issues. Participants encouraged to set both
step count and time in MVPA goals,
encouraged to start low and go slow.
Walking planner to help them plan when
and where and with whom they planned to
walk. Goals reviewed and reset at each
consultation.
“3,000-steps-in-30-minutes” message
for PA intensity.
Targets could be adapted in discussion
with nurse.
“3,000-steps-in-30-minutes” message for
PA intensity.
12-week PA and step count diary
(including behaviour-change
techniques)
Postedb and encouraged to return
completed diary to researchers after
12-week intervention.
Given by nurse at first appointment,
reviewed by nurse at other appointments
and encouraged to return completed
diary to researchers after 12-week
intervention.
Given by nurse at first appointment and
reviewed at each nurse appointment.
aThis table has been adapted from tables in the published trial protocols [26,27]. These are open-access articles published under licence to BioMed Central and
distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction, provided the work is
properly cited (http://creativecommones.org/licenses/by/2.0).
bResearcher telephoned 1 week later to check whether programme had arrived.
Abbreviations: approx., approximately; MVPA, moderate-to-vigorous PA; PA, physical activity.
https://doi.org/10.1371/journal.pmed.1002836.t002
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4-year follow-up (15/SC0352), which required us to reconsent participants at 4 year to access
further data from their primary care records, as trial follow-up was being restarted. The trial
had a control arm (usual care) and an intervention arm whose participants received the
12-week PACE-Lift walking programme (pedometer, handbook, PA diary, and feedback on
their accelerometry measures) at the first of four practice nurse PA consultations. Baseline
findings for participants included in primary care outcome analyses are summarised in
Table 1, and the intervention is summarised in Table 2. The protocol, approved by ethics
before extended follow-up commenced, included details of long-term follow-up, primary care
data download, and primary care data outcomes and is included (S3 Text), as is a CONSORT
checklist for primary care data follow-up (S4 Text).
Sample size
Power calculations for each of the trials have been described previously in the PACE-UP [27]
and PACE-Lift [26] trial protocols and were related to the primary outcome of change in
objectively measured PA levels at prespecified time points. The sample size was determined by
the number of trial participants providing consent for primary care data download, and the
confidence intervals (CIs) around our estimates give a clear indication of the level of precision
of our findings.
Outcome measures
A priori we wanted to evaluate intervention effects on long-term health outcomes relevant to
walking interventions assessed from primary care records 4 years post-baseline. These out-
come measures were not described in the original published trial protocols [26, 27], as they
were not planned at the time of study design, but they were prespecified in the protocols
approved by ethics (S1 and S3 Text), ahead of long-term data collection, and were designed to
be measurable retrospectively from primary care data. We defined these health outcomes as
nonfatal cardiovascular events (myocardial infarction, coronary artery bypass graft, angio-
plasty, transient ischaemic attack, and stroke), total cardiovascular events (cardiovascular
deaths plus nonfatal cardiovascular events), new onset diabetes, new onset depression episode,
injurious falls (those recorded in primary care records), and fractures. Cardiovascular disease
and depression outcomes were estimated both for those with and without prior cardiovascular
disease or depression, respectively. We also examined the effect of the interventions on num-
ber of primary care consultations (excluding the 3-month intervention period, as consultations
were part of the nurse intervention arms for both trials).
Procedures
We downloaded primary care data for trial participants who gave written consent, minus
those who subsequently withdrew from the trials, for the 4-year periods following randomisa-
tion from the seven PACE-UP and three PACE-Lift practices. Data were downloaded at 12
months (at end of initial trial follow-up) and at 4 years (after extended follow-up) at all 10
practices. If participants had both sets of data, the 12-month data were not needed, as they
were duplicated in the 4-year data. For those without any data at 4 years, 12-month data were
used, if available. See CONSORT diagram (Fig 1) for details of numbers of participants at each
time point with primary care data for both trials. Data on participants were censored if a
patient left the practice or if they died whilst still registered at the practice. Searches were set
up to download the following information from primary care records: Read codes for diseases
(including those arising from hospital admissions) and consultation data (see S1 Fig for details
of exactly how events were counted). For cardiovascular events and depression, we separated
Long-term health outcomes following 2 pedometer interventions
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events occurring in participants with and without preexisting disease, so Read codes for these
diseases that occurred prior to the individual randomisation date were taken as evidence of
preexisting disease. Prior Read codes for diabetes were used to exclude those with preexisting
diabetes at date of randomisation from subsequent diabetes analyses only, so that we could
estimate numbers of new type 2 diabetes diagnoses. Data were processed blind to trial group,
by a researcher without access to trial data apart from randomisation dates, according to an
agreed protocol. Two medically qualified researchers, also blind to intervention group, sepa-
rately checked that the events counted were appropriate. Details on deaths (including date and
cause) were collected systematically for both trials from general practices prior to recontacting
participants for long-term follow-up (at 3 years for PACE-UP and 4 years for PACE-Lift) and
were therefore available for all participants for this period of follow-up (regardless of whether
they had given permission for their primary care records to be downloaded), apart from any
patients who had deregistered with their practice by moving away. Known deaths from cardio-
vascular causes were counted as outcome events and included in total cardiovascular events;
other deaths were treated as censored data. Once all events had been verified, the primary care
data and trial data were linked.
Fig 1. (a) PACE-UP and (b) PACE-Lift CONSORT diagrams for primary care records analyses. Complete data for 4 years were only available on those participants
who were registered at the same primary care practice at baseline and 4 years. 7 deaths in PACE-UP participants (2 Control. 5 Intervention) and 4 deaths in PACE-Lift
participants (2 Control. 2 Intervention) were recorded on registered patients. Data for those participants who moved away or had died before 4 years are censored when
they left the practice or at their date of death.
https://doi.org/10.1371/journal.pmed.1002836.g001
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Statistical analysis
Analyses were carried out in STATA version 15.0 (StataCorp). We combined data from both
trials and modelled the effect of the interventions on cardiovascular, diabetes, fracture, and
depression outcomes using Cox regression models to estimate Cox hazard ratios (and 95%
CIs) for time to first event post-randomisation, adjusting for age (as a continuous variable),
sex, and study. For cardiovascular disease and depression, we repeated analyses excluding
those with a prior cardiovascular disease or depression diagnosis. For all these outcomes, we
also calculated Kaplan-Meier survival curves. For falls and consultations, in which we wanted
to allow for multiple events to be counted, we used negative binomial regression, which models
the counts as a Poisson process but allows for overdispersion. These models were used to esti-
mate incident rate ratios (and 95% CIs), also adjusting for age, sex, and study. We estimated
absolute risk reductions (ARRs) and used the approach recommended by Altman to calculate
the number needed to treat (NNT) for each estimate and its confidence limits [30, 31].
Patient and public involvement
Pilot work with older primary care patients from three general practices was carried out pre-
funding, with focus groups discussing ideas for a pedometer-based PA intervention. They pro-
vided input into study design—for example, encouraging postal recruitment and recruitment
of couples as well as individuals. Both trials had a patient advisor as a Trial Steering Committee
member; they were involved in discussions about study conduct and advised on patient mate-
rials, dissemination of results to participants, and safety reporting. All trial participants were
provided with individual feedback after 12-month follow-up. Trial results were disseminated
at the following times: after baseline assessments, after analysis of the main 12-month results,
and after 3-year (PACE-UP) or 4-year (PACE-Lift) follow-up. A trial website summarising
trial results and publications was created for PACE-UP (http://www.paceup.sgul.ac.uk) and
circulated to participants. Intervention burden was assessed by nurse group participants as
part of trial process evaluations [32] and by samples of all the intervention groups as part of
the qualitative evaluations [33, 34].
Results
Overall, 98% (1,297/1,321) of initial trial participants gave written consent for primary care
data linkage and had their data downloaded—1,001/1,023 (98%) from PACE-UP and 296/298
(99%) from PACE-Lift at baseline—and 223/225 (99%) of PACE-Lift participants recontacted
at 4-year follow-up. Primary care data available at different time points are shown in the two
flow diagrams (Fig 1a and 1b). Overall, 82% (1,077/1,321) of participants had 4 years of com-
plete data: 85% (871/1,023) of PACE-UP and 69% (206/298) of PACE-Lift participants.
Table 3 presents the time to first event for each outcome; the model coefficients are given in
S1 Table. For nonfatal cardiovascular events, in both trials the proportion of events was lower
in the intervention than in the control group, both for those without a prior cardiovascular
diagnosis and for all participants. The hazard ratios for all participants were 0.24 (95% CI
0.07–0.77, p = 0.02) (demonstrated in a Kaplan-Meier plot in Fig 2) and for those without a
prior diagnosis 0.27 (95% CI 0.08–0.88, p = 0.03). When fatal cardiovascular events were
included, results were similar: hazard ratios of 0.34 (95% CI 0.12–0.91, p = 0.03) for all partici-
pants and 0.31 (95% CI 0.11–0.93, p = 0.04) for those without a prior diagnosis. In terms of
new diabetes diagnoses, there was no statistically significant intervention effect, with a hazard
ratio of 0.75 (95% CI 0.42–1.36, p = 0.34). Similarly, for new depression diagnoses, there was
no overall effect of the intervention, hazard ratio 0.98 (95% CI 0.46–2.07, p = 0.96) in all partic-
ipants and 0.92 (95% CI 0.41–2.03, p = 0.83) in those without a prior diagnosis. For fractures,
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in PACE-UP the proportion of patients with a fracture during follow-up was lower in the
intervention group (26/668, 3.9%) compared with the control group (28/333, 8.4%); for
PACE-Lift both groups had similar proportions of fractures, 5.4% (8/149) in the intervention
group and 5.4% (8/147) in the control group. The overall Cox regression hazard ratio across
both trials was significantly reduced (0.56, 95% CI 0.35–0.90, p = 0.02). Fig 2 also shows these
findings in a Kaplan-Meier time-to-first-event diagram.
Table 4 shows the findings for medically reported falls and consultations; S1 Table shows
the coefficients. Overall, approximately 14% (115/818) of intervention and 13% (63/480) of
control participants had one or more falls during follow-up; the overall incident rate ratio for
falls was 1.07 (95% CI 0.78–1.46, p = 0.67). The mean number of consultations per year over
4-year follow-up was similar in intervention and control groups for both trials (approximately
6, with a standard deviation of 5), and the incident rate ratio was 1.01 (95% CI 0.93–1.10,
p = 0.82), showing no intervention effect on number of consultations.
Table 5 shows the ARRs and NNTs (95% CIs) for each event, combined across both trials.
The results for cardiovascular events and fractures (for which our interventions were associ-
ated with a protective effect) for all participants were as follows: nonfatal cardiovascular events
ARR 1.7% (0.5%–2.1%), NNT 59 (48–194); total cardiovascular events ARR 1.6% (0.2%–
2.2%), NNT 61 (46–472); fractures ARR 3.6% (0.8%–5.4%), NNT 28 (19–125).
Discussion
Statement of principal findings
Ninety-eight percent of trial participants gave written consent for their primary care records to
be used and had data successfully downloaded. Our results indicate that 12-week pedometer-
Table 3. PACE-UP and PACE-Lift studies. Hazard ratios for first events after randomisation in primary care records.
PACE-UP PACE-Lifta PACE-UP and PACE-Lift HRsb
Event Recorded in
Primary Care Record
N Control
(n = 333)
Intervention
(n = 668)
N Control
(n = 147)
Intervention
(n = 149)
N Control
(n = 480)
Intervention
(n = 817)
HR (95% CI) p-Value
Nonfatal cardiovascular events
All participants 1,001 7 (2.1%) 3 (0.4%) 296 3 (2.0%) 1 (0.7%) 1,297 10 (2.1%) 4 (0.5%) 0.24 (0.07–0.77) 0.02
No previous cardiac
diagnosis
937 6 (1.9%) 3 (0.5%) 265 3 (2.3%) 1 (0.8%) 1,202 9 (2.0%) 4 (0.5%) 0.27 (0.08–0.88) 0.03
Nonfatal and fatal cardiovascular events
All participants 1,001 7 (2.1%) 4 (0.6%) 297 4 (2.7%) 2 (1.3%) 1,298 11 (2.3%) 6 (0.7%) 0.34 (0.12–0.91) 0.03
No previous cardiac
diagnosis
937 6 (1.9%) 3 (0.5%) 266 4 (3.0%) 2 (1.5%) 1,203 10 (2.3%) 5 (0.7%) 0.31 (0.11–0.93) 0.04
Diabetes diagnosis
No previous diabetes
diagnosis
931 16 (5.2%) 21 (3.4%) 278 4 (2.9%) 5 (3.5%) 1,209 20 (4.5%) 26 (3.4%) 0.75 (0.42–1.36) 0.34
Depression diagnosis
All participants 1,001 11 (3.3%) 15 (2.2%) 296 0 (0.0%) 4 (2.7%) 1,297 11 (2.3%) 19 (2.3%) 0.98 (0.46–2.07) 0.96
No previous depression
diagnosis
902 10 (3.3%) 13 (2.2%) 262 0 (0.0%) 3 (2.3%) 1,164 10 (2.3%) 16 (2.2%) 0.92 (0.41–2.03) 0.83
Fractures
All participants 1,001 28 (8.4%) 26 (3.9%) 296 8 (5.4%) 8 (5.4%) 1,297 36 (7.5%) 34 (4.2%) 0.56 (0.35–0.90) 0.02
aOne PACE-Lift participant in the intervention group died before 12 months, and primary care records are not available. This participant has only been included in the
analyses of nonfatal + fatal cardiovascular events, so the denominators for these analyses are 150 for the PACE-Lift intervention group and 818 for the combined
intervention group.
bEstimates from the Cox regression models are adjusted for age, sex, and study.
Abbreviation: HR, hazard ratio.
https://doi.org/10.1371/journal.pmed.1002836.t003
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based walking interventions delivered through primary care, which led to long-term PA
increases of approximately 30 minutes per week of MVPA in the intervention groups, were
associated with significant decreases in both new cardiovascular events and fractures at 4
years. NNTs to avoid an event were approximately 60 for a cardiovascular event and 28 for a
fracture. There was no intervention effect on number of consultations, suggesting that changes
in consulting affecting recording of events could not explain these results. Our findings are
important because they demonstrate long-term clinical benefits that apply to all those rando-
mised, not only to those with trial follow-up data; clinical benefit also argues against explaining
the PA differences at different time points as only being short-term changes during weeks
when participants knew their PA levels were being measured. Our study thus demonstrates
the advantage of using routine data to evaluate long-term health outcomes in trials and also in
subsequent implementation studies.
Strengths and weaknesses of the study
Important strengths were that both trials recruited from primary care and that we sought par-
ticipant consent to use their primary care data, thus allowing us to examine long-term health
Fig 2. Kaplan-Meier curves for time to first event post-randomisation recorded in primary care records.
https://doi.org/10.1371/journal.pmed.1002836.g002
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outcomes using routinely collected data. Having two trials with similar recruitment methods
and interventions, which we had previously combined for long-term follow-up [25], meant
that we increased the power of our analyses. A key strength of UK routinely recorded primary
care data, which may not apply to other healthcare systems, is that it fully captures secondary
care diagnoses from accident and emergency, outpatients, and hospital admissions (National
Health Service and private), in addition to primary care consultations and diagnoses, thus
Table 4. PACE-UP and PACE-Lift studies. Incident rate ratios for falls and consultations after randomisation from primary care records.
PACE-UP PACE-Lift PACE-UP and PACE-Lift
Control Intervention Control Intervention Control Intervention Incident Rate Ratioa
(n = 333) (n = 668) (n = 147) (n = 149) (n = 480) (n = 818) IRR (95% CI) p-Value
Number of falls
n (%) n (%) n (%) n (%) n (%) n (%)
0 285 (86%) 574 (86%) 132 (90%) 128 (86%) 417 (87%) 702 (86%)
1 39 (12%) 80 (12%) 10 (7%) 15 (10%) 49 (10%) 95 (12%)
2 8 (2%) 11 (2%) 2 (1%) 3 (2%) 10 (2%) 14 (2%)
3+ 1 (0.3%) 3 (0.3%) 3 (2%) 3 (2%) 4 (1%) 6 (1%)
Falls and consultations: Rate per year of follow-up
Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Falls 0.04 (0.12) 0.05 (0.14) 0.04 (0.14) 0.05 (0.15) 0.04 (0.13) 0.05 (0.14) 1.07 (0.78–1.46) 0.67
Consultationsb 5.9 (4.8) 6.1 (5.1) 6.1 (4.6) 6.2 (5.9) 5.9 (4.8) 6.1 (5.3) 1.01 (0.93–1.10) 0.82
aNegative binomial models were used to estimate incident rate ratios. These model the count as Poisson with extra variation; the dispersion parameter is the expected
mean. All models adjust for age, sex, and study.
bConsultations in the first 90 days after randomisation are not included, as intervention group participants in both studies had practice nurse consultations during this
time as part of the intervention.
https://doi.org/10.1371/journal.pmed.1002836.t004
Table 5. PACE-UP and PACE-Lift studies combined: ARRs and NNTs for primary care recorded events.
Event recorded in primary care record N ARRa (95% CI) NNTb (95% CI)
Nonfatal cardiovascular events
All participants 1,297 1.7 (0.5–2.1) 59 (48–194)
No previous cardiac diagnosis 1,202 1.6 (0.3–2.0) 62 (50–386)
Nonfatal and fatal cardiovascular events
All participants 1,298 1.6 (0.2–2.2) 61 (46–472)
No previous cardiac diagnosis 1,203 1.7 (0.2–2.2) 60 (46–562)
Diabetes diagnosis
No previous diabetes diagnosis 1,209 1.2 (−1.7 to 2.8) 84 (NNTH 59 to1 to NNTB 35)
Depression diagnosis
All participants 1,297 0.1 (−2.7 to 1.4) 1,873 (NNTH 37 to1 to NNTB 72)
No previous depression diagnosis 1,164 0.2 (−2.6 to 1.5) 463 (NNTH 39 to1 to NNTB 66)
Fractures
All participants 1,297 3.6 (0.8–5.4) 28 (19–125)
aARR is calculated as 1/NNT.
bNNT/NNTB is the number needed to treat to show benefit from the intervention (i.e., prevent one event) at 4 years.
Where the 95% CI for ARR is consistent with an increase in risk from the intervention, the NNTH is also shown [31].
NNT is calculated using the formula 1/{SurvC��HR–SurvC} where SurvC is the Kaplan-Meier survival probability in
the control group at 4 years and HR is the hazard ratio [30].
Abbreviations: ARR, absolute risk reduction; NNT, number needed to treat; NNTH, number needed to harm.
https://doi.org/10.1371/journal.pmed.1002836.t005
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reducing potential for bias in outcome assessment. The inevitable losses that occur when col-
lecting long-term trial follow-up data can be reduced by using routinely collected data for out-
come assessment. We followed up 67% (681/1,023) of participants at 3 years in PACE-UP [25]
and 76% (225/298) at 4 years for PACE-Lift with objective PA primary outcome data, but for
these analyses using routinely collected primary care data at 4 years, we had 98% (1,297/1,321)
contributing to analyses and 82% (1,077/1,321) providing complete data over the whole 4
years, despite needing to reconsent PACE-Lift participants at 4-year follow-up. Others have
shown how higher levels of electronic follow-up (93%) compared with fieldwork follow-up
(83%) at 2 years retained more of those in the most deprived groups [35], demonstrating
reduced potential for selection bias.
An important limitation is that we did not have complete 4 years of follow-up data for all
participants; however, differences were already evident in cardiovascular events and fractures
by 12-month follow-up, when we had over 97% complete primary care data across all groups.
We were also constrained by the data routinely recorded in primary care records, which do
not reflect all cases. For cardiovascular events and fractures, underrecording is unlikely to have
been a problem, as major diagnoses like myocardial infarction, stroke, coronary artery bypass
graft, fractures, etc., are well recorded in primary care records following hospital notification
of events. For falls and new depression episodes, cases occurring in the community but not
reported to primary care will be missed, and for diabetes, new cases are only diagnosed when
blood tests are done. However, although cases will be underrecorded in primary care records
for these conditions, there is no reason for this to differ by intervention status, particularly as
the intervention did not affect consultation rate, so this should not have led to bias. A further
limitation is the uncertainty of our estimates. Given the low event rate in this sample and the
relatively short follow-up period for events, the CIs are wide, indicating uncertainty regarding
the exact magnitudes of effect.
Comparisons with previous studies
Details of all the intervention studies that are referred to in this section, including more infor-
mation on the specific interventions and their effects on PA levels, are summarised in S2 Table.
Cardiovascular events. The reductions we demonstrated in nonfatal (0.24 [95% CI 0.07–
0.77]) and total (0.34 [95% CI 0.12–0.91]) cardiovascular events are consistent with the effect in
older primary care patients 2 years after a 9-month PA programme that significantly increased
self-reported PA and significantly decreased blood pressure and lipids (reduction in cardiovas-
cular events risk ratio 0.15 [95% CI 0.04–0.51]) [15]. Similarly, others showed significant reduc-
tions in both heart attacks (relative risk 0.51) and strokes (relative risk 0.52) alongside self-
reported PA increases, 6 months post-intervention in community-based hypertension patients
[16]. However, Newman et al found no cardiovascular event reduction in the PA group at
2.6-year follow-up in older adults with functional limitations (hazard ratio 1.10 [95% CI 0.85–
1.42]) [17]. Possible reasons were that the PA intervention group had more opportunity to
report events; cardiovascular disease levels were high, possibly precipitating events or reducing
potential benefits; and there was a possible suboptimal activity dose, as their moderate PA cut-
off was>760 counts/minute [17], much lower than ours (�1,952 counts/minute) [26, 27].
Comparisons with risk estimates from cohort studies are more difficult. A key issue is that
all cohort studies in systematic reviews are based on questionnaire PA measures, with their
known inaccuracies and recall bias [7]; the variety of different questionnaires also makes it dif-
ficult to standardise how PA is quantified. Cohort studies’ effect estimates usually compare
inactive participants with those achieving much higher PA levels. Thus, a recent good-quality
systematic review provides relative risks for an 11.25 metabolic equivalent (MET) hour/week
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increase in PA levels compared with being inactive of 0.69 (95% CI 0.67–0.71) [36], corre-
sponding to international recommendations of 150 minutes of MVPA weekly in�10-minute
bouts [37]. Our intervention increased PA by about 30 minutes of MVPA in bouts weekly
long-term, one-fifth of 150 minutes, so after scaling down the relative risks from that paper
[36] (S5 Text), their cardiovascular incidence effect estimate for the same level of PA increase
becomes 0.98 (95% CI 0.97–0.99), suggesting a much more modest effect on cardiovascular
events than from our intervention study.
Type 2 diabetes. We showed a nonsignificant reduction in type 2 diabetes cases (0.75
[95% CI 0.42–1.36]), consistent with a pedometer intervention in UK primary care prediabetes
patients, which increased PA by 498 steps/day (162–834) across the 3-year follow-up and
achieved a hazard ratio for type 2 diabetes cases of 0.74 (95% CI 0.48–1.14) [14]. The signifi-
cant 58% reduction in diabetes incidence seen in the Finnish Diabetes Prevention trial (with a
combined PA/dietary intervention) occurred with not only an increase in PA levels (86% of
the intervention group achieving >4 hour/week of exercise compared with 71% of controls,
p = 0.001) but also dramatic weight loss (4.2 ± sd 5.1 kg in the intervention group versus
0.8 ± sd 3.7 kg in controls) [13].
From cohort studies, the scaled-down estimate of effect for type 2 diabetes incidence (as
done for cardiovascular disease, above) to compare appropriately with the PA increase
achieved in our trials was 0.93 (95% CI 0.92–0.93) (S5 Text), consistent with our estimate.
Fractures. The reduction in fractures observed in the intervention groups compared with
controls 0.56 (95% CI 0.35–0.90) is consistent with findings from a systematic review of exer-
cise interventions in older adults that gave a pooled risk ratio of 0.60 (95% CI 0.45–0.85) [20]
for fall-related fractures. However, only one of the 15 included studies was a pure walking
intervention, and several studies focused on strength and balance training and did not include
any walking component [20].
A meta-analysis of 13 cohort studies reported a relative risk for fractures of 0.62 (95% CI
0.56–0.69) in women [5] and 0.55 (95% CI 0.44–0.69) in men [5]. As for cardiovascular dis-
ease, these benefits are based on varying PA levels at baseline, but generally considerably
greater than 30 minutes of MVPA from walking weekly, and thus need scaling back. Given
the heterogeneity of exposure difference in the meta-analysis, it is difficult to provide such a
scaled-back estimate.
Falls. We did not observe any reduction in medically reported falls (overall negative bino-
mial regression incident rate ratio 1.07 [95% CI 0.78–1.46]). However, only primary care–
recorded falls were captured. Although others have seen falls reduced by exercise interventions
0.86 (95% CI 0.77–0.94) [20] and 0.77 (95% CI 0.71–0.83) [38], most interventions included
balance, resistance, and strength training and not simply walking. Walking is something of a
paradox for risk of falling, as it can increase falls by increasing exposure. Those interventions
that have reduced falls successfully in older adults have usually additionally included balance
components [19, 20, 38], whereas pure walking interventions have sometimes increased falls
[18], though not always [39].
A cohort study examining the association between regular walking and falls amongst com-
munity-dwelling older adults found that it did not increase falls for those at low risk (hazard
ratio 0.88 [95% CI 0.48–1.62]), but it significantly increased risk in those with two or more risk
factors for falling (hazard ratio 1.89 [95% CI 1.04–3.43]) [40], suggesting that the relationship
between walking and falls is complex.
Depression. We found no intervention effect on new depression cases (hazard ratio 0.98
[95% CI 0.46–2.07]), although CIs were very wide. A systematic review and meta-analysis of
PA interventions reported reduced depression symptoms (standardised mean effect size 0.37
[95% CI 0.24–0.50] for supervised PA studies and 0.52 [95% CI 0.28–0.77] for unsupervised
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studies) [21], supported by a systematic review of exercise referral schemes, which also showed
reduced clinical depression risk in the two studies reporting this outcome (pooled standard-
ised mean difference −0.82 [95% CI −1.28 to −0.35]) [41]. Of note, most studies included in
the reviews reported depression risk based on symptom scores rather than clinical diagnoses
of depression; we extracted the latter from primary care records, which could underestimate
depression risk, as it relies on patients presenting with symptoms and general (family) practi-
tioners detecting and recording them. Our negative finding from primary care records is, how-
ever, consistent with our main trial outcomes, which showed no intervention effects on
depressive symptoms at 12 months [23, 24] or 3–4 years [25].
Cohort studies support an association between PA levels and depression, with increased PA
levels associated with reduced depression risk, with the majority of studies (25/30) in a system-
atic review reporting this, though no meta-analyses or forest plots were presented [42], so
there is no overall effect estimate for direct comparison with our findings.
Implications for clinicians, researchers, and policy makers
An important implication for both future clinical practice and policy is that primary care
short-term pedometer-based walking interventions incorporating behaviour-change tech-
niques can lead not only to long-term changes in PA levels but also to long-term beneficial
health effects for adults and older adults. They could thus help to address the public health
physical inactivity challenge and be part of the ‘call to activity’ for clinicians and patients [43].
This supports current guidance to promote pedometers alongside support for goal-setting,
self-monitoring, and feedback [44] and suggests that policy makers should consider invest-
ment in this short-term primary care pedometer-based walking intervention because of its
proven long-term health benefits. Our previous work has shown that sustained effects on PA
levels were similar for postal and nurse-supported intervention groups [25] and that the postal
route was more cost-effective [28]; this route therefore seems most promising to pursue for
implementation.
Our demonstration of the widespread acceptance by trial participants for their primary care
records to be accessed and the feasibility of using these data for evaluating long-term health
outcomes is consistent with others’ findings [22, 35]. Our experience supports initiatives from
funders such as the Medical Research Council and the National Institute for Health Research
in the UK and other funders internationally, to encourage researchers undertaking trials to
include options for longer-term data collection from routine records in their funding applica-
tions. We found only one other example of a PA trial that used routine primary care data to
assess long-term health outcomes [15]. Using such outcomes provides objective evidence
applying to all those randomised (not just those who complete trial follow-up), and by focusing
on the clinical benefits, it also avoids the problems inherent in measuring change in PA levels
in large numbers of subjects. Linking healthcare data to trial data can strengthen the evaluation
and implementation of primary care–based interventions and should be more widely explored
by researchers.
Unanswered questions and future research
Observational studies strongly suggest that the dose-response association between PA levels
and both all-cause mortality [45] and a range of chronic diseases [36] is nonlinear, with the
greatest benefit appearing when changing from a sedentary lifestyle to low levels of activity
and smaller additional benefits from higher levels of activity [36, 45]. Such data have influ-
enced the newly published Physical Activity Guidelines for Americans [46]. Our data, based
on RCT evidence, are important for silencing the sceptics who argue that the new guidelines
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lack high-quality evidence from RCTs [43]. It is too soon to conclude with any confidence that
relatively modest changes in PA can achieve greater health benefits than predicted from cohort
studies, but that is the hope. Observational studies, even those using objective PA measures,
cannot provide direct evidence of what happens when individuals change their PA levels by
modest amounts; what is needed is for more PA trials that have successfully increased PA lev-
els to provide long-term follow-up of clinical outcomes.
Conclusions
We showed significant reductions in both cardiovascular events and fractures for the PA inter-
vention groups from two trials over a 4-year period, supporting and extending the benefits
demonstrated by the long-term trial PA outcomes. However, our CIs are wide, indicating
uncertainty regarding the exact magnitudes of the effects. We also confirmed the feasibility of
using routine primary care data to provide robust long-term health outcomes for RCTs. Short-
term 12-week pedometer-based walking interventions can have long-term positive health
effects and should be used more widely to help address the public health physical inactivity
challenge.
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